Search research articles
Contact Us
Filters
Showing results (11-20 of 38) with videos related to
Page
of 4
Sort By:
Bone Marrow Transplantation
|
July 23, 2022
Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT
Christian Koenecke, Dirk-Jan Eikema, Sheree Hazelaar, et al.
Bone Marrow Transplantation
|
December 20, 2017
Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT
Gwendolyn van Gorkom, Michel van Gelder, Dirk-Jan Eikema, et al.
Haematologica
|
August 16, 2023
SARS-CoV-2 vaccination in 361 non-transplanted patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria
Morag Griffin, Dirk-Jan Eikema, Inge Verheggen, et al.
European Journal of Haematology
|
April 21, 2023
Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP-EBMT study
Nico Gagelmann, Dirk-Jan Eikema, Linda Koster, et al.
American Journal of Hematology
|
February 19, 2021
Haplo-identical or mismatched unrelated donor hematopoietic cell transplantation for Fanconi anemia: Results from the Severe Aplastic Anemia Working Party of the EBMT
Josune Zubicaray, Daria Pagliara, Julian Sevilla, et al.
Blood Cancer Journal
|
September 27, 2022
Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT
Kavita Raj, Dirk-Jan Eikema, Vipul Sheth, et al.
American Journal of Hematology
|
March 18, 2024
HLA-haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties
Stefano Giardino, Dirk-Jan Eikema, Brian Piepenbroek, et al.
Blood Advances
|
January 28, 2026
Pregnancy after Haematopoietic Stem Cell Transplant: an international multicentre study
Nina Salooja, Dirk-Jan Eikema, David Michonneau, et al.
Haematologica
|
March 23, 2023
Graft-<i>versus</i>-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT
Raynier Devillier, Dirk-Jan Eikema, Carlo Dufour, et al.
Transplantation and Cellular Therapy
|
September 20, 2021
Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Firoozeh Sahebi, Dirk-Jan Eikema, Linda Koster, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 38) with videos related to
Sort By:
Page
of 4
Bone Marrow Transplantation
|
July 23, 2022
Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT
Christian Koenecke, Dirk-Jan Eikema, Sheree Hazelaar, et al.
Bone Marrow Transplantation
|
December 20, 2017
Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT
Gwendolyn van Gorkom, Michel van Gelder, Dirk-Jan Eikema, et al.
Haematologica
|
August 16, 2023
SARS-CoV-2 vaccination in 361 non-transplanted patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria
Morag Griffin, Dirk-Jan Eikema, Inge Verheggen, et al.
European Journal of Haematology
|
April 21, 2023
Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP-EBMT study
Nico Gagelmann, Dirk-Jan Eikema, Linda Koster, et al.
American Journal of Hematology
|
February 19, 2021
Haplo-identical or mismatched unrelated donor hematopoietic cell transplantation for Fanconi anemia: Results from the Severe Aplastic Anemia Working Party of the EBMT
Josune Zubicaray, Daria Pagliara, Julian Sevilla, et al.
Blood Cancer Journal
|
September 27, 2022
Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT
Kavita Raj, Dirk-Jan Eikema, Vipul Sheth, et al.
American Journal of Hematology
|
March 18, 2024
HLA-haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties
Stefano Giardino, Dirk-Jan Eikema, Brian Piepenbroek, et al.
Blood Advances
|
January 28, 2026
Pregnancy after Haematopoietic Stem Cell Transplant: an international multicentre study
Nina Salooja, Dirk-Jan Eikema, David Michonneau, et al.
Haematologica
|
March 23, 2023
Graft-<i>versus</i>-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT
Raynier Devillier, Dirk-Jan Eikema, Carlo Dufour, et al.
Transplantation and Cellular Therapy
|
September 20, 2021
Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Firoozeh Sahebi, Dirk-Jan Eikema, Linda Koster, et al.
Page
of 4